The Relationship Between Intestinal Microbiota and the Central Nervous System in Normal Gastrointestinal Function and Disease  Stephen M. Collins, Premsyl.

Slides:



Advertisements
Similar presentations
GI Pathophysiology Jaeyoung Chun, M.D. Pathophysiology
Advertisements

The Functional–Organic Dichotomy: Postinfectious Irritable Bowel Syndrome and Inflammatory Bowel Disease–Irritable Bowel Syndrome  Madhusudan Grover,
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Volume 141, Issue 5, Pages (November 2011)
Postinfectious Irritable Bowel Syndrome
Volume 141, Issue 5, Pages (November 2011)
Volume 141, Issue 2, Pages e3 (August 2011)
Diet as a Therapy for Irritable Bowel Syndrome: Progress at Last
Gastrointestinal Stromal Tumors: Disease and Treatment Update
Nicholas A. Bokulich, Martin J. Blaser  Cell Metabolism 
Volume 152, Issue 4, Pages (March 2017)
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Figure 2 The microbiome–gut–brain axis
Volume 141, Issue 5, Pages (November 2011)
Covering the Cover Gastroenterology
The Functional–Organic Dichotomy: Postinfectious Irritable Bowel Syndrome and Inflammatory Bowel Disease–Irritable Bowel Syndrome  Madhusudan Grover,
Volume 141, Issue 2, Pages e3 (August 2011)
Volume 141, Issue 4, Pages e5 (October 2011)
Volume 145, Issue 6, Pages e1 (December 2013)
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Nadir Arber, Bernard Levin  Gastroenterology 
Volume 133, Issue 5, Pages (November 2007)
Kirsten Tillisch, Jennifer S. Labus  Gastroenterology 
Genetics and Genomics in the Practice of Medicine
Volume 140, Issue 3, Pages e5 (March 2011)
David L. McCollum, J. Martin Rodriguez 
Defensins Versus Bacteria: Not Just Antibiotics Anymore
Ira J. Fox, Stephen C. Strom  Gastroenterology 
The Functional Gastrointestinal Disorders and the Rome III Process
Making Sense of HDAC2 Mutations in Colon Cancer
Volume 141, Issue 5, Pages (November 2011)
Volume 154, Issue 5, Pages (April 2018)
Volume 144, Issue 5, Pages (May 2013)
Volume 133, Issue 3, Pages e1 (September 2007)
Eamonn M.M. Quigley  Clinical Gastroenterology and Hepatology 
Khursheed N. Jeejeebhoy  Gastroenterology 
The Role of Obesity and Related Metabolic Disturbances in Cancers of the Colon, Prostate, and Pancreas  Edward Giovannucci, Dominique Michaud  Gastroenterology 
Intestinal Inflammation and Cancer
Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis
Volume 138, Issue 5, Pages (May 2010)
Volume 139, Issue 6, Pages e1 (December 2010)
Are Proton Pump Inhibitors Affecting Intestinal Microbiota Health?
Volume 139, Issue 6, Pages (December 2010)
Therapeutic Potential of Fecal Microbiota Transplantation
Gastrointestinal Stromal Tumors: Disease and Treatment Update
Volume 133, Issue 2, Pages (August 2007)
Impact of New Hepatitis C Treatments in Different Regions of the World
Peripheral and Central P2X3 Receptor Contributions to Colon Mechanosensitivity and Hypersensitivity in the Mouse  Masamichi Shinoda, Bin Feng, G.F. Gebhart 
Treatment of Clostridium difficile-Associated Disease
Volume 153, Issue 4, Pages (October 2017)
Coffee and Colorectal Cancer: Grounds for Prevention?
Genetic Testing for Hereditary Colorectal Cancer: Challenges in Identifying, Counseling, and Managing High-Risk Patients  Elena M. Stoffel, Anu Chittenden 
Volume 150, Issue 5, Pages (May 2016)
Volume 150, Issue 7, Pages (June 2016)
Volume 155, Issue 2, Pages (August 2018)
Volume 148, Issue 3, Pages (March 2015)
Volume 149, Issue 6, Pages (November 2015)
Volume 153, Issue 6, Pages (December 2017)
Volume 156, Issue 1, Pages e7 (January 2019)
Risk of Irritable Bowel Syndrome After an Episode of Bacterial Gastroenteritis in General Practice: Influence of Comorbidities  Ana Ruigómez, Luis Alberto.
Volume 147, Issue 4, Pages (October 2014)
Postinfectious Irritable Bowel Syndrome
Would Free Fatty Acids Enhance Treatment of Obesity?
Volume 138, Issue 6, Pages (May 2010)
Quantitative Meta-analysis Identifies Brain Regions Activated During Rectal Distension in Irritable Bowel Syndrome  Kirsten Tillisch, Emeran A. Mayer,
The Future of Endoscopic Retrograde Cholangiopancreatography
Bowel Urgency in Patients With Irritable Bowel Syndrome
Treating Inflammatory Bowel Disease With Diet: A Taste Test
Covering the Cover Gastroenterology
Working hypothesis on the role of low grade inflammation in the pathogenesis of irritable bowel syndrome. Working hypothesis on the role of low grade inflammation.
Presentation transcript:

The Relationship Between Intestinal Microbiota and the Central Nervous System in Normal Gastrointestinal Function and Disease  Stephen M. Collins, Premsyl Bercik  Gastroenterology  Volume 136, Issue 6, Pages 2003-2014 (May 2009) DOI: 10.1053/j.gastro.2009.01.075 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 The effect of antibiotic-induced perturbation of the intestinal microbiota on myeloperoxidase activity (A), immune-reactive substance P in the intestinal wall (B), and visceromotor response to balloon distension in mice (C) with or without treatment with Lactobacillus paracasei. AB, antibiotic; ATB, antibiotic; AUC, area under the curve; Con, control; CRD, colorectal distension; LB, lactobacillus. Adapted with permission from Verdu et al.29 Gastroenterology 2009 136, 2003-2014DOI: (10.1053/j.gastro.2009.01.075) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 (A) The interrelationship of the intestinal microbiota and gastrointestinal physiology and inflammation in health (A) and in the presence of intestinal dysbiosis (B). (A) The gastrointestinal tract under normal conditions provides a stable habitat for commensal bacteria that supports the structural and functional integrity of the gut. The stable bacterial population in turn supports normal gut physiology. (B) Disturbance of (1) normal gut physiology or (2) the microbiota destabilizes the habitat, resulting in change in physiologic inflammation which in turn alters physiology. Gastroenterology 2009 136, 2003-2014DOI: (10.1053/j.gastro.2009.01.075) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 The effect of mild restraint stress on plasma adrenocorticotrophic hormone (ACTH) concentrations in germ-free and colonized young mice. Adapted with permission from Sudo et al.64 Gastroenterology 2009 136, 2003-2014DOI: (10.1053/j.gastro.2009.01.075) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 The effect of antibiotic-induced perturbation of the microbiota in mice. Mice were treated with bacitracin, neomycin, and primaricin28 by gavage for 7 days. Behavior was assessed in the step-down test (left), and in the light box–dark box test (middle and right). Responses of control mice are shown in the yellow bars and those of antibiotic-treated mice are shown in the blue bars. Antibiotic-treated mice showed a significantly lower latency to step-down, greater time spent in the white box, and an increased number of crossovers between the light and dark boxes. ATB, antibiotics. Gastroenterology 2009 136, 2003-2014DOI: (10.1053/j.gastro.2009.01.075) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 A hypothetical model describing the role of the intestinal microbiota in the pathogenesis of irritable bowel syndrome. In this model, known risk factors for IBS that include gastroenteritis, antibiotic use, and stress produce changes in commensal bacteria and an increment in physiologic inflammation. This leads to changes in gut function as a basis for abdominal symptom generation. Perturbation of the microbiota may contribute to the behavioral profile seen in this condition. Gastroenterology 2009 136, 2003-2014DOI: (10.1053/j.gastro.2009.01.075) Copyright © 2009 AGA Institute Terms and Conditions

Figure 6 The integration of the intestinal microbiota into the brain–gut axis (GBA). Shown are the putative mechanisms whereby the brain may influence the composition of the intestinal microbiota, and whereby the microbiota may influence the brain. The communication between these systems is bidirectional. These are the components of the proposed bidirectional microbiota–gut–brain axis. CNS, central nervous system; EE, entero-endocrine. Gastroenterology 2009 136, 2003-2014DOI: (10.1053/j.gastro.2009.01.075) Copyright © 2009 AGA Institute Terms and Conditions

Stephen M. Collins Gastroenterology 2009 136, 2003-2014DOI: (10.1053/j.gastro.2009.01.075) Copyright © 2009 AGA Institute Terms and Conditions

Premysl Bercik Gastroenterology 2009 136, 2003-2014DOI: (10.1053/j.gastro.2009.01.075) Copyright © 2009 AGA Institute Terms and Conditions